Update on chemoprevention for prostate cancer

Current Opinion in Urology

Volumn 20, Issue 3, 2010, Pages 194-197

  Strope, Seth A ^a   Andriole, Gerald L ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

Chemoprevention; Primary prevention; Prostate cancer

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; DUTASTERIDE; FINASTERIDE; FOLIC ACID; PLACEBO; SELENIUM;

CANCER DIAGNOSIS; CANCER GRADING; CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLON CANCER; COLORECTAL ADENOMA; COST EFFECTIVENESS ANALYSIS; DRUG COST; HUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SECONDARY PREVENTION; VITAMIN SUPPLEMENTATION;

AZASTEROIDS; CHEMOPREVENTION; ENZYME INHIBITORS; FINASTERIDE; HUMANS; MALE; PROSTATIC NEOPLASMS; RISK FACTORS; VITAMINS;

EID: 77951295180     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3283381966     Document Type: Review

References (18)

1. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003; 349:215-224. (Pubitemid 36859473)
2. Cohen YC, Liu KS, Heyden NL, et al. Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2007; 99:1366-1374.
3. Pinsky P, Parnes H, Ford L. Estimating rates of true high-grade disease in the prostate cancer prevention trial. Cancer Prev Res (Phila Pa) 2008; 1:182-186.
4. Redman MW, Tangen CM, Goodman PJ, et al. Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach. Cancer Prev Res (Phila Pa) 2008; 1:174-181.
5. Kaplan SA, Roehrborn CG, Meehan AG, et al. PCPT: evidence that finasteride reduces risk of most frequently detected intermediate-and high-grade (Gleason score 6 and 7) cancer. Urology 2009; 73:935-939.
6. Kramer BS, Hagerty KL, Justman S, et al. Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/ American Urological Association 2008 Clinical Practice Guideline. J Clin Oncol 2009; 27:1502-1516.
7. Zeliadt SB, Etzioni RD, Penson DF, et al. Lifetime implications and costeffectiveness of using finasteride to prevent prostate cancer. Am J Med 2005; 118:850-857.
8. Svatek RS, Lee JJ, Roehrborn CG, et al. Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis. Cancer 2008; 112:1058-1065.
9. Andriole G, Bostwick D, Brawley O, et al. Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial. J Urol 2004; 172 (4 Pt 1):1314-1317. (Pubitemid 39249705)
10. Lippman SM, Goodman PJ, Klein EA, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst 2005; 97:94-102. (Pubitemid 40277089)
11. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009; 301:39-51.
12. Christen WG, Gaziano JM, Hennekens CH. Design of Physicians' Health Study II: a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol 2000; 10:125-134.
13. Gaziano JM, Glynn RJ, Christen WG, et al. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA 2009; 301:52-62.
14. Figueiredo JC, Grau MV, Haile RW, et al. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst 2009; 101:432-435.
15. Comstock GW, Bush TL, Helzlsouer K. Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 1992; 135:115-121.
16. Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998; 90:1219-1224. (Pubitemid 28407088)
17. Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996; 276:1957-1963.
18. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention study group. N Engl J Med 1994; 330:1029-1035.